Financials Synektik Spólka Akcyjna
Equities
SNT
PLSNKTK00019
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
130 PLN | -1.66% | +0.78% | +51.16% |
Valuation
Fiscal Period: September | 2019 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 122.8 | 516.9 | 1,128 | - | - |
Enterprise Value (EV) 1 | 126.4 | 473.1 | 1,049 | 1,039 | 987.4 |
P/E ratio | 12.7 x | 9.5 x | 15.4 x | 14.6 x | 13.1 x |
Yield | 2.5% | - | 2.59% | 2.13% | 2.66% |
Capitalization / Revenue | 0.91 x | 1.16 x | 2.18 x | 2.17 x | 2.05 x |
EV / Revenue | 0.94 x | 1.06 x | 2.02 x | 1.99 x | 1.79 x |
EV / EBITDA | 7.02 x | 4.81 x | 9.78 x | 9.62 x | 8.42 x |
EV / FCF | - | 5.62 x | 19.2 x | 19.6 x | 12.8 x |
FCF Yield | - | 17.8% | 5.22% | 5.11% | 7.81% |
Price to Book | 1.74 x | - | - | - | - |
Nbr of stocks (in thousands) | 8,529 | 8,529 | 8,529 | - | - |
Reference price 2 | 14.40 | 60.60 | 132.2 | 132.2 | 132.2 |
Announcement Date | 11/8/19 | 11/14/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: September | 2019 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | 134.8 | 446.9 | 518.1 | 520.8 | 551.1 |
EBITDA 1 | 18.01 | 98.29 | 107.3 | 108 | 117.3 |
EBIT 1 | 12.78 | 68.79 | 91.27 | 81.3 | 99.51 |
Operating Margin | 9.48% | 15.39% | 17.62% | 15.61% | 18.06% |
Earnings before Tax (EBT) 1 | 12.02 | 68.19 | 90.27 | 95.61 | 106.1 |
Net income 1 | 9.605 | 54.39 | 73.12 | 64.22 | 79.46 |
Net margin | 7.13% | 12.17% | 14.11% | 12.33% | 14.42% |
EPS 2 | 1.130 | 6.380 | 8.570 | 9.080 | 10.07 |
Free Cash Flow 1 | - | 84.18 | 54.77 | 53.06 | 77.11 |
FCF margin | - | 18.84% | 10.57% | 10.19% | 13.99% |
FCF Conversion (EBITDA) | - | 85.64% | 51.06% | 49.14% | 65.74% |
FCF Conversion (Net income) | - | 154.77% | 74.9% | 82.63% | 97.05% |
Dividend per Share 2 | 0.3600 | - | 3.430 | 2.815 | 3.515 |
Announcement Date | 11/8/19 | 11/14/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: September | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 |
---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | 35.76 | 58.38 | - | 65.66 | 101.7 | 135.7 | 271.3 | 98.4 |
EBITDA 1 | - | - | 12.81 | 29.78 | 10.91 | 24.9 | 32.71 | 53.15 | 18.1 |
EBIT 1 | - | - | 5.578 | 24.63 | 3.183 | 21.08 | 23.95 | 45.37 | 9.1 |
Operating Margin | - | - | 9.55% | - | 4.85% | 20.73% | 17.64% | 16.72% | 9.25% |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - |
Net income | 7.701 | 0.3473 | 2.66 | 19.08 | 4.029 | 13.52 | 17.76 | - | - |
Net margin | - | 0.97% | 4.56% | - | 6.14% | 13.29% | 13.08% | - | - |
EPS | 0.9000 | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - |
Announcement Date | 6/14/22 | 8/9/22 | 11/22/22 | 2/15/23 | 6/6/23 | 8/8/23 | 11/14/23 | 2/14/24 | - |
Balance Sheet Analysis
Fiscal Period: September | 2019 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt 1 | 3.62 | - | - | - | - |
Net Cash position 1 | - | 43.8 | 78.7 | 88.8 | 140 |
Leverage (Debt/EBITDA) | 0.2009 x | - | - | - | - |
Free Cash Flow 1 | - | 84.2 | 54.8 | 53.1 | 77.1 |
ROE (net income / shareholders' equity) | 14.5% | 48.6% | 46.3% | 37.7% | 33.4% |
ROA (Net income/ Total Assets) | 8.3% | 20.4% | 23% | 21.4% | 20.8% |
Assets 1 | 115.7 | 266.9 | 317.4 | 299.7 | 381.6 |
Book Value Per Share | 8.290 | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex 1 | 5.7 | 9.97 | 16 | 13.2 | 13.8 |
Capex / Sales | 4.23% | 2.23% | 3.09% | 2.53% | 2.5% |
Announcement Date | 11/8/19 | 11/14/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+51.16% | 279M | |
+8.06% | 219B | |
+6.70% | 183B | |
+11.59% | 133B | |
+26.00% | 108B | |
+1.44% | 63.06B | |
+11.80% | 52.02B | |
-0.62% | 48.2B | |
-0.15% | 40.37B | |
+12.97% | 39.35B |
- Stock Market
- Equities
- SNT Stock
- Financials Synektik Spólka Akcyjna